A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA ...

Mark Mallon, Chief Executive Officer of George Medicines, said: “Data show that most patients with hypertension will require two or more medicines to bring their blood pressure under control.

Widaplik marks the first and only FDA-approved triple combination medication that can be used as an initial therapy for patients with hypertension who require multiple drugs to reach their blood ...

Mark Mallon, Chief Executive Officer of George Medicines, said: "Data show that most patients with hypertension will require two or more medicines to bring their blood pressure under control. WIDAPLIK ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.